Sutro Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	65.93	190.3	69.27	47.25	30.41	206.15
Short-Term Investments	101.67	126.59	306.35	287.11	167.52	161.99
Cash & Short-Term Investments	167.59	316.9	375.62	334.36	197.94	368.14
Cash Growth	-56.83%	-15.63%	12.34%	68.92%	-46.23%	212.34%
Accounts Receivable	3.92	8.62	36.08	7.12	12.45	5.56
Other Current Assets	10.6	17.8	9.85	11.67	8.12	4.49
Total Current Assets	182.11	343.31	421.54	353.15	218.52	378.18
Net Property, Plant & Equipment	26.69	35.87	44.76	51.06	51.59	12.94
Long-Term Investments	-	-	-	-	68.78	-
Other Long-Term Assets	0.86	8.03	4.44	2.73	2.53	2.99
Total Assets	209.66	387.21	470.74	406.94	341.41	394.11
Accounts Payable	7.03	10.48	9.44	4.8	6.01	5.54
Accrued Expenses	47.92	44.16	53.16	27.91	19.82	8.82
Current Portion of Long-Term Debt	-	-	4.06	12.5	9.38	-
Current Portion of Leases	7.96	7.48	6.42	4.59	1.04	-
Unearned Revenue	8.98	69.78	20.67	16.76	5.5	14.6
Other Current Liabilities	-	-	-	-	-	0.63
Total Current Liabilities	71.9	131.89	93.75	66.55	41.74	29.6
Long-Term Debt	-	-	-	3.77	15.74	24.55
Long-Term Leases	9.7	15.67	23.15	29.57	31.22	-
Other Long-Term Liabilities	215.33	195.04	204.19	90	0.15	7.92
Total Long-Term Liabilities	225.03	210.71	227.34	123.35	47.11	32.47
Total Liabilities	296.93	342.61	321.09	189.9	88.84	62.06
Common Stock	0.09	0.08	0.06	0.06	0.05	0.05
Additional Paid-in Capital	843.81	831.35	708.98	670.22	586.24	559.75
Accumulated Other Comprehensive Income	0.03	0.04	0.02	-0.62	-0.31	0.13
Retained Earnings	-931.19	-786.87	-559.41	-452.62	-333.41	-227.87
Shareholders' Equity	-87.27	44.6	149.65	217.05	252.56	332.05
Total Liabilities & Equity	209.66	387.21	470.74	406.94	341.41	394.11
Total Debt	17.66	23.15	33.64	50.43	57.37	24.55
Net Cash (Debt)	149.93	293.74	341.98	283.93	140.56	343.59
Net Cash Growth	-48.96%	-14.11%	20.45%	102.00%	-59.09%	218.18%
Net Cash Per Share	17.90	38.23	56.84	55.96	30.48	105.48
Book Value	-87.27	44.6	149.65	217.05	252.56	332.05
Book Value Per Share	-10.42	5.81	24.87	42.78	54.76	101.94
Tangible Book Value	-87.27	44.6	149.65	217.05	252.56	332.05
Tangible Book Value Per Share	-10.42	5.81	24.87	42.78	54.76	101.94

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q